Inspiremd Stock Analysis

InspireMD Stock Analysis Notes

About 21.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.61. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. InspireMD recorded a loss per share of 0.71. The entity last dividend was issued on the 1st of April 2019. The firm had 1:15 split on the 27th of April 2021. InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel. Inspiremd operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 50 people. To find out more about InspireMD contact Marvin Slosman at 972 3 6917691 or learn more at https://www.inspiremd.com.

InspireMD Investment Alerts

InspireMD Upcoming and Recent Events

InspireMD Largest EPS Surprises

View All Earnings Estimates

InspireMD Environmental, Social, and Governance (ESG) Scores

InspireMD Thematic Classifications

InspireMD Stock Institutional Investors

Note, although InspireMD's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

InspireMD Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 63.38 M.

InspireMD Profitablity

Management Efficiency

InspireMD has return on total asset (ROA) of (0.3724) % which means that it has lost $0.3724 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6675) %, meaning that it created substantial loss on money invested by shareholders. InspireMD's management efficiency ratios could be used to measure how well InspireMD manages its routine affairs as well as how well it operates its assets and liabilities. As of 01/30/2025, Return On Tangible Assets is likely to drop to -0.4. In addition to that, Return On Capital Employed is likely to drop to -0.61. At this time, InspireMD's Total Assets are relatively stable compared to the past year. As of 01/30/2025, Total Current Assets is likely to grow to about 53.3 M, while Other Assets are likely to drop slightly above 506 K.

Technical Drivers

As of the 30th of January, InspireMD retains the Risk Adjusted Performance of 0.0124, market risk adjusted performance of (0.17), and Downside Deviation of 3.3. Concerning fundamental indicators, the technical analysis model lets you check existing technical drivers of InspireMD, as well as the relationship between them. Please check out InspireMD information ratio and downside variance to decide if InspireMD is priced fairly, providing market reflects its last-minute price of 2.57 per share. Please also validate InspireMD total risk alpha, which is currently at (0.30) to confirm the company can sustain itself at a future point.

InspireMD Price Movement Analysis

InspireMD Insider Trading Activities

InspireMD Outstanding Bonds

InspireMD Predictive Daily Indicators

InspireMD Corporate Filings

InspireMD Forecast Models

InspireMD's time-series forecasting models are one of many InspireMD's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary InspireMD's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how InspireMD prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling InspireMD shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as InspireMD. By using and applying InspireMD Stock analysis, traders can create a robust methodology for identifying InspireMD entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. InspireMD analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. InspireMD analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

InspireMD stock analysis indicators help investors evaluate how InspireMD stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading InspireMD shares will generate the highest return on investment. By understating and applying InspireMD stock analysis, traders can identify InspireMD position entry and exit signals to maximize returns.

When running InspireMD's price analysis, check to measure InspireMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InspireMD is operating at the current time. Most of InspireMD's value examination focuses on studying past and present price action to predict the probability of InspireMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InspireMD's price. Additionally, you may evaluate how the addition of InspireMD to your portfolios can decrease your overall portfolio volatility.